Skip to main content
Log in

H2 antagonist and omeprazole nonresponders

  • Letters to the Editor
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bianchi Porro G, Parente F: Duodenal ulcers resistant to H2 blockers: An emerging therapeutic problem. Scand J Gastroenterol 23(suppl 153):81–88, 1988

    Google Scholar 

  2. Savarino V, Mela GS, Scalabrini P, Celle G: H2-receptor antagonist non-responders. Lancet 2:1281, 1987

    Google Scholar 

  3. Wagner S, Freise J, Schmidt FW: H2-receptor antagonist nonresponders. Lancet 1:128, 1988

    Google Scholar 

  4. Johnston D, Wormsley KG: H2 receptor antagonist nonresponders. Lancet 1:129, 1988

    Google Scholar 

  5. Rogers MJ, Holmfield J, Primrose J, Gledhill T, Johnston D: Why refractory duodenal ulcers do not heal? Gut 29:A1441, 1988

    Google Scholar 

  6. Collen MJ, Stanczak VJ, Ciarleglio CA: Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication). Dig Dis Sci 34:233–237, 1989

    Google Scholar 

  7. Heald KA, Fielding JWL, Macdonald F: Binding assay to predict response to H2 antagonists. Lancet 1:323, 1989

    Google Scholar 

  8. Wilder-Smith CH, Ernst T, Gennoni M, Zeyen B, Halter F, Merki HS: Tolerance to oral H2-receptor antagonists. Dig Dis Sci 35:976–983, 1990

    Google Scholar 

  9. Savarino V, Mela GS, Zentilin P, Celle G: Duodenal ulcer resistant to usual omeprazole dose. Am J Gastroenterol 85:618–619, 1990

    Google Scholar 

  10. Savarino V, Mela GS, Zentilin P, Magnolia MR, Scalabrini P, Valle F, Moretti M, Bonifacino G, Celle G: Gastric aspiration versus antimony and glass pH electrodes: A simultaneous comparativein vivo study. Scand J Gastroenterol 24:434–439, 1989

    Google Scholar 

  11. Clissold SP, Campoli-Richards DM: Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32:15–47, 1986

    Google Scholar 

  12. Lanzon-Miller J, Pounder RE, Hamilton MR, Ball S, Chronos NAF, Raymond F, Olausson M, Cederberg C: Twenty-four hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:239–251, 1987

    Google Scholar 

  13. Savarino V, Mela GS, Sumberaz A, Celle G: Omeprazole in H2 blocker non-responders. Gut 31:584, 1990

    Google Scholar 

  14. Klinkeberg-Knol EC, Meuwissen SGM: Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 4:485–495, 1990

    Google Scholar 

  15. Maton PN, Vinayek R, Frucht H, McArthur KA, Miller RS, Saeed ZA, Gardner JD, Jensen RT: Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study. Gastroenterology 97:827–836, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savarino, V., Mela, G.S., Vigneri, S. et al. H2 antagonist and omeprazole nonresponders. Digest Dis Sci 36, 1172–1173 (1991). https://doi.org/10.1007/BF01297469

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01297469

Keywords

Navigation